Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…
Read More »Cancer
Three hospital systems across England have begun a live clinical trial of AI technology designed to detect and grade prostate…
Read More »
A collaborative study has uncovered microproteins exclusive to liver tumors, presenting a new avenue for cancer vaccine development. These microproteins…
Read More »
Dr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar…
Read More »
In a major genetic study, over 5,000 variants linked to increased cancer risk were identified in the BAP1 gene, revealing…
Read More »
Developed by MIT researchers, Leuko’s device offers a noninvasive method for cancer patients to monitor their immune health at home.…
Read More »
A breakthrough treatment uses nutrient-based nanomedicine to reactivate dormant metabolic pathways in cancer cells, effectively stopping melanoma growth. This new…
Read More »
Research at Georgia State University focusing on Ethiopian medicinal plants is showing potential in combating cervical cancer. Led by Professor…
Read More »
Fibrolamellar carcinoma (FLC), a rare liver cancer in young people, is caused by a gene fusion due to a chromosome…
Read More »
UCLA researchers have enhanced immunotherapy for malignant gliomas by combining a dendritic cell vaccine with poly-ICLC, showing promising improvements in…
Read More »